In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company last year. CEO Stéphane Bancel laid out a plan to reverse that.
Hannah Green, Biz Journals
Wed, 01/08/2025 - 12:38pm